Align aldehyde dehydrogenase (NAD+) (EC 1.2.1.3) (characterized)
to candidate WP_012968262.1 KVAR_RS13410 succinate-semialdehyde dehydrogenase
Query= BRENDA::A6T8Z5 (462 letters) >NCBI__GCF_000025465.1:WP_012968262.1 Length = 461 Score = 902 bits (2332), Expect = 0.0 Identities = 455/461 (98%), Positives = 458/461 (99%) Query: 2 MNLSATHAVSVNPTTGEVVSSLPWASEREVDAAITLAAAGYRQWRQTPLADRADALRRIG 61 MNLSATHAVSVNPTTGEVVSSLPWASEREVDAAI LAAAGYRQWRQTPLA+RADALRRIG Sbjct: 1 MNLSATHAVSVNPTTGEVVSSLPWASEREVDAAIALAAAGYRQWRQTPLAERADALRRIG 60 Query: 62 AALRARGEEVAQMITLEMGKPIAQARGEVAKSANLCDWYAEHGPAMLATEATLVENNQAV 121 AALRARGEEVAQMITLEMGKPIAQARGEVAKSANLCDWYAEHGPAMLATEAT VENNQAV Sbjct: 61 AALRARGEEVAQMITLEMGKPIAQARGEVAKSANLCDWYAEHGPAMLATEATQVENNQAV 120 Query: 122 IEYRPLGAILAVMPWNFPVWQVMRGAVPILLAGNSYLLKHAPNVMGSARLLGEIFAAAGL 181 IEYRPLGAILAVMPWNFPVWQV+RGAVPILLAGNSYLLKHAPNVMGSARLLGEIFAAAGL Sbjct: 121 IEYRPLGAILAVMPWNFPVWQVLRGAVPILLAGNSYLLKHAPNVMGSARLLGEIFAAAGL 180 Query: 182 PDGVFGWVNATNDGVSQIINDDRIAAVTVTGSVRAGKAIGAQAGAALKKCVLELGGSDPF 241 PDGVFGWVNATNDGVSQIINDDRIAAVTVTGSVRAGKAIGAQAGAALKKCVLELGGSDPF Sbjct: 181 PDGVFGWVNATNDGVSQIINDDRIAAVTVTGSVRAGKAIGAQAGAALKKCVLELGGSDPF 240 Query: 242 IVLNDADLDEAVKAAVTGRYQNSGQVCAASKRFILEAGIAEAFTRKFVDAVAALKMGDPR 301 IVLNDADLDEAVKAAVTGRYQNSGQVCAASKRFILEA IA+AFTRKFVDAVAALKMGDPR Sbjct: 241 IVLNDADLDEAVKAAVTGRYQNSGQVCAASKRFILEADIADAFTRKFVDAVAALKMGDPR 300 Query: 302 DEQNYVGPMARFDLRDELHQQVTATLDEGATLLLGAEKIEGAGNYYAPTVLGNVTAGMTG 361 DEQNYVGPMARFDLRDELHQQVTATLDEGATLLLGAEKIEGAGNYYAPTVLGNVTAGMTG Sbjct: 301 DEQNYVGPMARFDLRDELHQQVTATLDEGATLLLGAEKIEGAGNYYAPTVLGNVTAGMTG 360 Query: 362 FRQELFGPVATLTTARDADHALALANDSEFGLSATVYTTDEAQAQRFARELECGGVFLNG 421 FRQELFGPVATLTTARDADHALALANDSEFGLSATVYTTDEAQAQRFARELECGGVFLNG Sbjct: 361 FRQELFGPVATLTTARDADHALALANDSEFGLSATVYTTDEAQAQRFARELECGGVFLNG 420 Query: 422 YCASDARVAFGGVKKSGFGRELSHFGLHEFCNAQTVWKDRR 462 YCASDARVAFGGVKKSGFGRELSHFGLHEFCNAQTVWKDRR Sbjct: 421 YCASDARVAFGGVKKSGFGRELSHFGLHEFCNAQTVWKDRR 461 Lambda K H 0.319 0.133 0.392 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 780 Number of extensions: 12 Number of successful extensions: 1 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 462 Length of database: 461 Length adjustment: 33 Effective length of query: 429 Effective length of database: 428 Effective search space: 183612 Effective search space used: 183612 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.8 bits) S2: 51 (24.3 bits)
This GapMind analysis is from Apr 09 2024. The underlying query database was built on Sep 17 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory